Philip Liebson to Hypertension
This is a "connection" page, showing publications Philip Liebson has written about Hypertension.
Connection Strength
2.081
-
Cardiovascular risk in special populations II: hypertension. Prev Cardiol. 2009; 12(4):189-97.
Score: 0.269
-
Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
Score: 0.232
-
VISP and INVEST. Prev Cardiol. 2004; 7(2):93-6.
Score: 0.190
-
ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
Score: 0.177
-
LIFE and ARBITER. Prev Cardiol. 2003; 6(2):108-11.
Score: 0.177
-
Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy. Curr Hypertens Rep. 2000 Jun; 2(3):260-70.
Score: 0.148
-
Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997 Mar 24; 157(6):638-48.
Score: 0.119
-
Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study). Am J Cardiol. 1995 Jun 15; 75(17):1233-8.
Score: 0.105
-
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995 Feb 01; 91(3):698-706.
Score: 0.102
-
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993 Feb; 87(2):476-86.
Score: 0.089
-
Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 1990 Jun; 3(6 Pt 1):512-7.
Score: 0.074
-
Hypertension research. Echocardiography in the measurement of left ventricular wall mass. Hypertension. 1987 Feb; 9(2 Pt 2):II2-5.
Score: 0.059
-
One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension. 2001 Nov; 38(5):1118-23.
Score: 0.041
-
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens. 2001 Jan; 19(1):127-34.
Score: 0.039
-
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension. 2000 Jan; 35(1 Pt 1):6-12.
Score: 0.036
-
Prevention of coronary heart disease. Part I. Primary prevention. Dis Mon. 1999 Dec; 45(12):497-571.
Score: 0.036
-
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension. 1997 Jan; 29(1 Pt 1):8-14.
Score: 0.029
-
Regression of left ventricular hypertrophy. JAMA. 1996 Aug 21; 276(7):526-7.
Score: 0.028
-
Is the echocardiogram an appropriate ECG validity standard for the detection and change in left ventricular size? J Electrocardiol. 1996; 29 Suppl:248-55.
Score: 0.027
-
Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study. Control Clin Trials. 1994 Oct; 15(5):395-410.
Score: 0.025
-
Population-derived comparisons of ambulatory and office blood pressures. Implications for the determination of usual blood pressure and the concept of white coat hypertension. Arch Intern Med. 1992 Apr; 152(4):750-6.
Score: 0.021
-
Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. Am J Cardiol. 1989 Jun 05; 63(19):69I-74I.
Score: 0.017
-
Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension. 1987 Feb; 9(2 Pt 2):II69-76.
Score: 0.015
-
Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke. 2005 Mar; 36(3):546-50.
Score: 0.013
-
Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
Score: 0.013